Hypersensitivity to carboplatin -: An effect of generic drugs?

被引:7
作者
Gernez, Y.
Barlesi, F.
Astoul, R.
Magnan, A.
机构
[1] Univ Mediterranee, Serv Oncol Thorac, Federat Malad Resp, Hop St Marguerite,Fac Med,Assistance Publ Hop Mar, F-13274 Marseille 09, France
[2] Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Hop St Marguerite,Serv Pneumol Allergol, Marseille, France
关键词
carboplatin; hypersensitivity; generic; drug safety; desensitisation; skin tests;
D O I
10.1016/S0761-8425(06)71577-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Carboplatin is a chemotherapeutic agent used frequently in thoracic medicine on account of its relatively good tolerance. Nevertheless hypersensitivity reactions have been described. Case reports We report the cases of 2 patients, treated for undifferentiated bronchial carcinoma and carcinoma of the breast, presenting with hypersensitivity reactions to carboplatin developing after 6 and 8 courses respectively. The first patient presented. with an irritant maculo-papular rash and the second with severe hypotension and bronchospasm. Neither of these reactions was fatal. Both of these reactions occurred when generic carboplatin was substituted for the propriety preparation. Conclusion Hypersensitivity reactions to carboplatin should be recognised by respiratory physicians on account of their potential seriousness and their occurrence after several courses of treatment. This takes on particular importance at a time when plans for domiciliary treatment of patients are being considered. In addition a national survey of hypersensitivity to carboplatin should be considered by the regional drug safety centres.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 9 条
[1]   Second-line treatment for advanced non-small cell lung cancer:: A systematic review [J].
Barlési, F ;
Jacot, W ;
Astoul, P ;
Pujol, JL .
LUNG CANCER, 2006, 51 (02) :159-172
[2]   Successful carboplatin desensitization in patients with proven carboplatin allergy [J].
Confino-Cohen, R ;
Fishman, A ;
Altaras, M ;
Goldberg, A .
CANCER, 2005, 104 (03) :640-643
[3]   Clinical features of hypersensitivity reactions to carboplatin [J].
Markman, M ;
Kennedy, A ;
Webster, K ;
Elson, P ;
Peterson, G ;
Kulp, B ;
Belinson, J .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1141-1145
[4]   Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity [J].
Markman, M ;
Zanotti, K ;
Peterson, G ;
Kulp, B ;
Webster, K ;
Belinson, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4611-4614
[5]   Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions [J].
Markman, M ;
Hsieh, F ;
Zanotti, K ;
Webster, K ;
Peterson, G ;
Kulp, B ;
Spicel, A ;
Belinson, J .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (01) :25-28
[6]   Chemotherapy for metastatic non-small cell lung cancer [J].
Pérol, M ;
Moro-Sibilot, D .
REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) :S131-S136
[7]   Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience [J].
Polyzos, A ;
Tsavaris, N ;
Kosmas, C ;
Arnaouti, T ;
Kalahanis, N ;
Tsigris, C ;
Giannopoulos, A ;
Karatzas, G ;
Giannikos, L ;
Sfikakis, PP .
ONCOLOGY, 2001, 61 (02) :129-133
[8]  
WEIDMANN B, 1994, CANCER, V73, P2218, DOI 10.1002/1097-0142(19940415)73:8<2218::AID-CNCR2820730830>3.0.CO
[9]  
2-1